DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Engelhardt M, Muller AM, Maier W. et al.
Severe irreversible bilateral hearing loss after bortezomib (VELCADE) therapy in a multiple myeloma (MM) patient.
Leukemia 2005; 19: 869-870
We do not assume any responsibility for the contents of the web pages of other providers.